Analyst Consensus
- Current Price
- 229.01 $
- Target (Low)
- 198.00 $
- Target (Mean)
- 246.67 $
- Target (High)
- 292.00 $
- Recommendation
- Buy
- Number of Analysts
- 26
Recommendation Distribution
Recommendation Distribution| Strong Buy | 3 |
|---|
| Buy | 12 |
|---|
| Hold | 10 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 2 |
|---|
Key Ratios
- Net Profit Margin
- 10.9%
- Operating Margin
- 21.0%
- Gross Margin
- 36.9%
- Return on Equity (ROE)
- 24.3%
- Return on Assets (ROA)
- 6.0%
- Revenue Growth
- 2.4%
- Earnings Growth
- -41.9%
- Debt/Equity
- 257.39
- Current Ratio
- 1.39
- Beta
- 0.84
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 11, 2026 | RBC Capital | Outperform → Outperform |
| Jun 10, 2026 | Bernstein | Market Perform |
| Jun 10, 2026 | Barclays | Overweight → Overweight |
| Jun 5, 2026 | RBC Capital | Outperform → Outperform |
| Jun 4, 2026 | RBC Capital | Outperform → Outperform |
| Jun 3, 2026 | Goldman Sachs | Buy → Buy |